Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jasna Trifunovic"'
Autor:
Jasna Pesic, Vladimir Vidovic, Ivana Kolarov Bjelobrk, Jasna Trifunovic, Nemanja Petrovic, Jelena Radic, Bojana Vranjkovic, Bojana Andrejic Visnjic
Publikováno v:
Journal of Chemotherapy. 34:264-271
The choice of the anti-HER2 agent depends on country-specific availability, the specific, previously administered anti-HER2 therapy and the relapse-free interval, although there is not much published data on the use of lapatinib after progression on
Autor:
Gorana Matovina-Brko, Milotka Fabri, Lazar Popovic, Danijela Petkovic, Jasna Trifunovic, Ivana Kolarov-Bjelobrk, Maja Ruzic
Publikováno v:
Journal of Chemotherapy. 26:180-183
Oncologists worldwide are often dealing with hepatitis C virus positive breast cancer patients, questioning adequate chemotherapy protocol, reduction of doses, delays, or even interruptions of treatment. We present a case of a woman in stage IIIB bre
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 145-147 (2003)
Locally advanced breast cancer is a specific clinic entity, comprising various degrees of breast cancer local and regional extension. This term is applied to nonmetastatic large primary tumors (including inflammatory breast carcinoma), with or withou